$2.20
0.115.26%
At close: -
$1.96
-0.24-10.87%
After Hours: Jan 29, 7:54 AM EDT
Comments
Loading...
Gain Therapeutics (NASDAQ:GANX) Stock, Earnings Estimates, EPS, And Revenue
Gain Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 25
EPS Estimate
$-0.170
Quarterly Revenue Estimate
$30.00K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of Gain Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Gain Therapeutics (GANX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-14 | $-0.17 | $-0.21 | 19.1 % |
| Q2 | 2024-08-08 | $-0.42 | $-0.20 | -110.0 % |
| Q1 | 2024-05-14 | $-0.22 | $-0.29 | 24.1 % |
| Q4 | 2024-03-26 | $-0.29 | $-0.32 | 9.38 % |
Gain Therapeutics (GANX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | 2024-08-08 | $0 | $400.00K | -100.0 % |
| Q1 | 2024-05-14 | $0 | $30.00K | -100.0 % |
| Q4 | 2024-03-26 | $0 | $320.00K | -100.0 % |
| Q2 | 2023-08-10 | $0 | $1.01M | -100.0 % |
FAQ
When is Gain Therapeutics (NASDAQ:GANX) reporting earnings?
Gain Therapeutics (GANX) is scheduled to report earnings on March 25, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for Gain Therapeutics (NASDAQ:GANX)?
The Actual EPS was $-0.17, which beat the estimate of $-0.21.
What were Gain Therapeutics’s (NASDAQ:GANX) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.